Director NEW MEXICO CLINICAL RESEARCH & OSTEOPOROSIS CENTER Albuquerque, NM, United States
Disclosure(s):
E Lewiecki, MD: Amgen: Advisory Board (), Speakers' Bureau (); Radius: Advisory Board (), Speakers' Bureau ()
Discover the latest evidence shaping midlife women’s health in this dynamic session featuring world-renowned experts. With new data highlighting the safety of hormone therapy and a resurgence of interest in its role, we’ll explore how to strike the right balance in clinical practice. The program also covers strategies to preserve bone health during the menopausal transition and reviews effective non-hormonal options for vasomotor symptoms. Attendees will leave with practical, evidence-based insights to optimize care for diverse patient needs.
Learning Objectives:
Evaluate current evidence-based strategies for managing menopausal symptoms, including hormonal and non-hormonal approaches, to optimize patient outcomes.
Apply updated clinical guidance for hormone therapy and bone health preservation during the menopausal transition.
Integrate individualized treatment plans that balance symptom relief, bone health, and patient safety across diverse clinical scenarios.
.jpg)
.jpg)
